Incentive Spirometry Versus Inspiratory Muscle Training After Coronary Artery Bypass Grafting (NCT07367945) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Incentive Spirometry Versus Inspiratory Muscle Training After Coronary Artery Bypass Grafting
Egypt45 participantsStarted 2026-02-01
Plain-language summary
This study will be conducted to compare between incentive spirometry verses inspiratory muscle training preoperatively on (ABG) after coronary artery bypass graft surgery.
Is there any significant difference of preoperative incentive spirometry verses inspiratory muscle training on Arterial blood gases (ABG) after coronary artery bypass graft surgery?
Participants will:
Group A (incentive spirometry group ) Group B (Inspiratory muscle trainer group ) for 5 days before operative Group C (control group) and group a , b will have routinely postoperative
Who can participate
Age range
50 Years – 60 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 45 male patients will be included in this study.
* Patients with age from 50 to 60 years old (undergoing coronary artery bypass graft surgery) through median sternotomy.
* Their body mass index from 25 to 29.9 kg/m2
* Patients will be alert and able to follow instruction.
Exclusion Criteria:
* Who are expected not to be able to conduct or comply with IS and IMT.
* Patients with cognitive or neurological deficits.
* Patients with coexisting acute or chronic respiratory disorders.
* Patients unable to understand or show the proper use of the incentive spirometer and Inspiratory muscle training .
* Patients who cannot be instructed or supervised to assure appropriate use of the device patients in whom cooperation is absent or patients unable to understand or demonstrate proper use of the devices (inspiratory muscle training and incentive spirometry).
* Patients who are confused or delirious.
* Patients undergoing any other surgery along with CABG.
* Patients undergoing emergency CABG surgery.
* Chronic obstructive pulmonary disease (COPD), asthma, restrictive lung disease, preoperative major chest infection e.g. pulmonary tuberculosis, chest deformities such as pectus carinatum, pectus excavatum, thoracolumbar scoliosis, diaphragmatic hernias diagnosed on history.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Arterial Blood gas Parameters (PaO2 and SaO2)
Timeframe: Baseline 5 days pre-surgery , Immediately after the surgery within 48 hours , and through study completion an average of 8 days.